Cargando…
A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth
The dineolignan manassantin A from Saururaceae was recently identified as a hypoxia-inducible factor 1 (HIF-1) inhibitor, but its in-vivo anti-tumor effect has not been explored. We synthesized a series of manassantin A derivatives, and found that replacing the central tetrahydrofuran moiety with a...
Autores principales: | Lang, Liwei, Liu, Xiaoyu, Li, Yan, Zhou, Qing, Xie, Ping, Yan, Chunhong, Chen, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4055733/ https://www.ncbi.nlm.nih.gov/pubmed/24925080 http://dx.doi.org/10.1371/journal.pone.0099584 |
Ejemplares similares
-
LXY6090 – a novel manassantin A derivative – limits breast cancer growth through hypoxia-inducible factor-1 inhibition
por: Lai, Fangfang, et al.
Publicado: (2016) -
Synthesis and Biological
Evaluation of Manassantin
Analogues for Hypoxia-Inducible Factor 1α Inhibition
por: Kwon, Do-Yeon, et al.
Publicado: (2015) -
Effect of manassantin B, a lignan isolated from Saururus chinensis, on lipopolysaccharide-induced interleukin-1β in RAW 264.7 cells
por: Park, Hwan Chul, et al.
Publicado: (2012) -
Manassantin B shows antiviral activity against coxsackievirus B3 infection by activation of the STING/TBK-1/IRF3 signalling pathway
por: Song, Jae-Hyoung, et al.
Publicado: (2019) -
Modulation of Tumor Hypoxia by pH-Responsive Liposomes to Inhibit Mitochondrial Respiration for Enhancing Sonodynamic Therapy
por: Zhang, Nan, et al.
Publicado: (2020)